07/13/2021 | Press release | Distributed by Public on 07/12/2021 20:00
DPM Heng Swee Keat at the Asia Tech X Singapore Summit 2021
Distinguished guests,
A very good morning.
This inaugural Summit takes place at a critical juncture, as we seek to recover from the global fallout of the COVID-19 pandemic.
The virus has taken the world by storm, in a manner that none of us could have imagined. 4 million lives have been lost. Countless livelihoods have been disrupted.
The pandemic sent the global economy into a tailspin, and the world is seeking to recover from its worst recession in a century.
Some are wondering if 2020 marked the end of a long period of globalisation as we know it.
Study finds virus antibodies last at least 12 months By WANG XIAOYU | CHINA DAILY | Updated: 2021-07-08 09:27 Share CLOSE A recovering pneumonia patient gives a thumbs-up to medical workers at Wuhan University s Zhongnan Hospital, in early 2020. [GAO XIANG/FOR CHINA DAILY]
Antibodies against the novel coronavirus can last for at least 12 months in more than 70 percent of recovered COVID-19 patients, a study published by Chinese researchers on Tuesday shows.
The finding adds to growing evidence that vaccination, which elicits an immune response in a way similar to how a live virus triggers human bodies to generate antibodies, can effectively restrict the spread of SARS-CoV-2 , the study said.
This handout illustration image obtained on Feb 27, 2020, courtesy of the National Institutes of Health, shows a transmission electron microscopic image showing SARS-CoV-2 also known as 2019-nCoV, the virus that causes Covid-19.
BEIJING (China Daily/ANN): Antibodies against the novel coronavirus can last for at least 12 months in more than 70 per cent of recovered Covid-19 patients, a study published by Chinese researchers on Tuesday (July 6) shows.
The finding adds to growing evidence that vaccination, which elicits an immune response in a way similar to how a live virus triggers human bodies to generate antibodies, can effectively restrict the spread of SARS-CoV-2 , the study said, referring to the novel coronavirus that causes Covid-19.
Antibodies against the novel coronavirus can last for at least 12 months in more than 70 percent of recovered COVID-19 patients, a study published by Chinese researchers on Tuesday shows.
The finding adds to growing evidence that vaccination, which elicits an immune response in a way similar to how a live virus triggers human bodies to generate antibodies, can effectively restrict the spread of SARS-CoV-2 , the study said.
The study, published online by Nature Communications, was conducted by China National Biotech Group, a Sinopharm subsidiary, and the National Research Center for Translational Medicine at Shanghai Jiao Tong University.
Researchers collected 1,782 convalescent plasma samples from 869 recovered COVID-19 patients in Wuhan, Hubei province, within 12 months of diagnosis, and tested them for the presence and amount of RBDIgG, a type of antibody that indicates the strength of immunity against the virus.
Endeavor China Appoints Sum Huang as New CEO
Rebecca Davis, provided by
FacebookTwitterEmail
Endeavor’s China subsidiary has appointed Sum Huang as its chief executive, the company said Tuesday.
Huang was most recently the co-founder and partner of Shanghai-headquartered content provider XG Entertainment, which raised capital from Alibaba CICC and YF Capital during his tenure. He helped the company build its content development and production business, produced live concerts, and established a branded content team that formed a TikTok-based multi-channel media business.
More from Variety
“Sum’s entrepreneurial background and deep understanding of media will help us enhance the strong offering we’ve built across entertainment, sports and fashion in China and APAC more broadly,” said Endeavor president Mark Shapiro. “In this next phase of our growth, Sum will ensure we continue delivering exceptional local-market expertise for our clients and partners while expandi